- Who We ServeWho We Serve
- SolutionsSolutions
- Patient ImpactPatient Impact
- Articles & InsightsArticles & Insights
- About UsAbout Us
Explore our articles and insights pages and leverage our subject matter experts' industry and field-level knowledge on various healthcare topics, from healthcare trends and research to technology and policy developments, as well as articles of particular value to specific roles in the industry. You can get started with our categories and also use the filter sidebar to find articles tailored to your interests and needs.
Access and affordability challenges and their solutions are different for drug brands depending on their lifecycle stage. CoverMyMeds presented a webinar with Fierce Pharma discussing their findings, summarized here.
The CoverMyMeds partnership with Latent Health delivers more intelligent AI automation for even faster FHIR-based Prior Authorization.
At HLTH USA 2025, Kevin Kettler, President of CoverMyMeds, joined fellow healthcare leaders on the panel session, “Patients Know First,” to explore how the industry can better align with the evolving expectations to ensure patients remain at the center of all decisions.
Explore five tactical changes—from proactive prior auth to hands-on patient assistance—that remove real-world barriers and improve therapy adherence.
Access and affordability challenges and their solutions are different for drug brands depending on their lifecycle stage. CoverMyMeds presented a webinar with Fierce Pharma discussing their findings, summarized here.
The CoverMyMeds partnership with Latent Health delivers more intelligent AI automation for even faster FHIR-based Prior Authorization.
At HLTH USA 2025, Kevin Kettler, President of CoverMyMeds, joined fellow healthcare leaders on the panel session, “Patients Know First,” to explore how the industry can better align with the evolving expectations to ensure patients remain at the center of all decisions.
Explore five tactical changes—from proactive prior auth to hands-on patient assistance—that remove real-world barriers and improve therapy adherence.